SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is seeing renewed market attention as traders monitor potential institutional interest and ETF speculation, fueling community debates over whether it can replicate its past breakout momentum. While some participants express frustration with price volatility and the broader memecoin landscape, others view the current consolidation as an accumulation phase in anticipation of a potential market-wide recovery tied to broader crypto sentiment.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging in conversation as a self-described Bitcoin parody that leans into its origins as an early 2011 internet joke to differentiate itself from newer meme coins. The community is actively debating its potential as a 'next-gen' asset, highlighting its long-standing lore and historical ties to the broader crypto ecosystem while dismissing recent unrelated copycats as scams.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently a focal point of intense community debate, with holders balancing optimistic speculation regarding potential supply burns and institutional status against widespread skepticism about its long-term performance. While some participants view current price levels as a strategic accumulation zone, others remain vocal about the asset's volatility and its historical correlation with broader market downturns.

Hormel Foods Corp. engages in the manufacturing and marketing of branded food products. It operates through the following segments: Retail, Foodservice, and International. The Retail segment consists of the processing, marketing, and sale of food products sold predominantly in the retail market. The Foodservice segment includes the processing, marketing, and sale of food and nutritional products for foodservice, convenience store, and commercial customers. The International segment focuses on processing, marketing, and selling company products internationally. The company was founded by George A. Hormel in 1891 and is headquartered in Austin, MN.

Hormel Foods Corp.

Hormel Foods is trending after a JPMorgan downgrade to neutral triggered a sell-off, with the community focused on cost pressures and the stock's persistent downtrend. While some investors remain attracted to the company's dividend yield and its role as a defensive staple, others express frustration over its underperformance and management's struggle to navigate inflationary headwinds.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is experiencing intense volatility, with investors debating whether current price levels present a buying opportunity or a signal of deeper long-term decline. Sentiment remains polarized as traders closely monitor technical support zones and potential regulatory updates, leading to active discussions about whether the asset is accumulating for a future breakout or facing a prolonged bear market.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is experiencing intense volatility and polarizing debate as the community clashes between "bulls" anticipating an altcoin season and "bears" labeling it a failing project. Discussions are heavily focused on the disconnect between the coin's stagnant market performance and its recent RWA narrative, with traders aggressively arguing over whether to accumulate or dump their positions.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is attracting significant attention as investors anticipate key regulatory milestones, specifically an upcoming FDA decision for ivonescimab. While some community members express frustration with recent price volatility and delays, others remain deeply bullish, pointing to strong trial data and a potential short squeeze as major catalysts for future growth.

Stubhub Holdings, Inc. provides online ticket selling services. It also provides services for buyers and sellers of tickets for sports, concerts, theater, and other live entertainment events. The company was founded by Eric H. Baker in 2000 and is headquartered in New York, NY.

Stubhub Holdings Inc. - Ordinary Shares - Class A

StubHub

StubHub is experiencing significant market volatility and heavy short interest as investors react to its post-IPO performance and lack of near-term guidance. The community remains deeply divided, with some betting on a potential short squeeze fueled by low float, while others express strong skepticism regarding the company's valuation, regulatory headwinds, and the sustainability of its business model in a cooling consumer economy.

Sweetgreen, Inc. owns and operates a chain of salad restaurants. It offers drinks, sides, local bowls, salads, plates, and warm bowls. The company was founded by Nicolas Jammet, Jonathan Neman, and Nathaniel E. Ru in November 2006 and is headquartered in Los Angeles, CA.

Sweetgreen Inc - Ordinary Shares - Class A

Sweetgreen is trending as market participants focus on significant insider accumulation, including a notable purchase by the CEO, fueling speculation about a potential short squeeze on the heavily shorted stock. Investors are closely monitoring the company's turnaround efforts, specifically the expansion of the 'Infinite Kitchen' technology and new menu additions like wraps, as they look for signs of a recovery in same-store sales and traffic stabilization.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is garnering attention as a core infrastructure play within the AI-Crypto narrative, with the community highlighting its deflationary mechanics and integration with AI-Intents technology as long-term catalysts. Despite recent price volatility, investors are actively discussing the protocol's developer traction and its potential for relative outperformance as capital rotates into high-beta ecosystems.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Terns Pharmaceuticals, Inc. (NasdaqGS: TERN) to...

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Hold" from Brokerages

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Get Free Report) have earned a consensus rating of "Hold" from the fourteen research firms that are covering the stock, Marketbeat Ratings...

Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?

Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 9, 2026 Insiders may stand to...

Promising Pharmaceutical Stocks To Add to Your Watchlist - April 9th

Eli Lilly and Company, Terns Pharmaceuticals, and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of companies engaged in the discovery, development, manufacturing, and sale of prescription drugs and related...

AZN vs. MRK: Which Oncology Stock Offers Better Investment Potential?

Though both dominate oncology, a stronger growth outlook and clearer targets may give AstraZeneca an edge over Merck.

Why Terns Pharmaceuticals Stock Rocked the Market in March

Key PointsAll told, the transaction is valued at around $6.7 billion...

Best Pharmaceutical Stocks To Consider - April 8th

Eli Lilly and Company, Terns Pharmaceuticals, Soleno Therapeutics, Pfizer, and AbbVie are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, and market presc...

Value Stocks To Add to Your Watchlist - April 7th

Invesco QQQ, Sandisk, Intel, ProShares UltraPro Short QQQ, and Terns Pharmaceuticals are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Value stocks are shares...

Top Mid Cap Stocks To Add to Your Watchlist - April 7th

ProShares UltraPro Short QQQ, Terns Pharmaceuticals, Direxion Daily TSLA Bull 2X Shares, Avis Budget Group, Applied Optoelectronics, Booking, and Soleno Therapeutics are the seven Mid Cap stocks to...

Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review

Merck cuts Terns deal price after TERN-701 data review, while maintaining interest amid competition and CML treatment comparisons.read more...

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Current Price	$52.63
Prev Close	$52.56
Open	$52.64
Dividend Yield	0.00%
50-Day Moving Average	$44.34
Beta	1.00
Avg. Volume	7.87M
PE Ratio	-50.97

52-Week High	$53.19
52-Week Low	$2.14
Market Capitalization	$6.07B
EPS (Annual)	-$1.03
Price to Book	5.87
Revenue Per Employee	$0.00

TERN
Terns Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TERN News

TERNTerns Pharmaceuticals Inc